Patients with nuclear ZNF16 positive carcinomas had a 3.287-fold (95% CI; 1.888–5.722) greater risk of death and a 3.038-fold (95% CI; 1.765–5.229) greater risk of relapse or death from gallbladder carcinoma. The gene discussed is ZNF16; the disease is gallbladder carcinoma.